Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

TLR-3 polymorphism is an independent prognostic marker for stage II colorectal cancer.

European journal of cancer (Oxford, England : 1990) - 1 May 2011

Castro F A, Försti A, Buch S, Kalthoff H, Krauss C, Bauer M, Egberts J, Schniewind B, Broering D C, Schreiber S, Schmitt M, Hampe J, Hemminki K, Schafmayer C

Abstract excerpt

BACKGROUND: Clinicopathologic stage is still the main parameter to evaluate the prognosis of newly diagnosed colorectal cancer (CRC) patients. Although molecular markers have been suggested for follow up of treated CRC patients, their complete clinical application is still under evaluation. MATERIALS AND METHODS: To evaluate the association of immune-related genes with CRC prognosis and survival, a total of 19...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cohort Studies
Share to Colorectal Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Germany

Share to Interleukin-10

Share to Lymphatic Metastasis

Share to Odds Ratio

Share to Promoter Regions, Genetic

Share to Toll-Like Receptor 3

Source

Identifiers

PMID: 21239167
DOI: 10.1016/j.ejca.2010.12.011

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

TLR-3 polymorphism is an independent prognostic marker for stage II colorectal cancer.PMID 21239167Read ↗

Genetic Insights into Interleukin-13 Polymorphisms in Colorectal Cancer Risk and Progression.Semantic proximity Read ↗

Positive link between variant Toll-like receptor 4 (Asp299Gly and Thr399Ile) and colorectal cancer patients with advanced stage and lymph node metastasis.Semantic proximity Read ↗

Evaluation of the detection of Toll-like receptors (TLRs) in cancer development and progression in patients with colorectal cancer.Semantic proximity Read ↗

The TIM-3 Rs10053538 Polymorphism Is Associated with Clinical Prognosis of Colorectal Cancer.Semantic proximity Read ↗

Association of -1112 c/t promoter region polymorphism of the interleukin 13 gene with occurrence of colorectal cancer.Semantic proximity Read ↗

A Seven-Gene Signature Aggregates a Subgroup of Stage II Colon Cancers with Stage IIISemantic proximity Read ↗

Single nucleotide polymorphisms within interferon signaling pathway genes are associated with colorectal cancer susceptibility and survival.Semantic proximity Read ↗

Impact of interleukin-10 gene polymorphisms on survival in patients with colorectal cancer.Semantic proximity Read ↗

Association of TLR2, TLR3, TLR4 and CD14 genes polymorphisms with oral cancer risk and survival.Semantic proximity Read ↗

Prognostic and predictive value of a microRNA signature in stage II colon cancer: a microRNA expression analysisSemantic proximity Read ↗

TLR3 gene polymorphisms in cancer: a systematic review and meta-analysis.Semantic proximity Read ↗

Prognostic significance of PLA2G4C gene polymorphism in patients with stage II colorectal cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.